Archon X Prize - Overview

Overview

The US$10 million prize is to be awarded to "the first Team that can build a whole human genome sequencing device and use it to sequence 100 human genomes within 30 days or less, with an accuracy of no more than one error in every 1,000,000 bases sequenced, with an accuracy rate of at least 98% of the genome, and at a recurring cost of no more than $1,000 (US) per genome." The $10 million was donated by Canadian geologist and philanthropist Stewart Blusson, who co-discovered the Ekati Diamond Mine. The name "Archon" is the name of Blusson's company, which refers to the type of lithosphere beneath northern Canada.

The 100 human genomes to be sequenced in this competition will be donated by 100 centenarians (ages 100 or older) from all over the world, known as the 100 Over 100. Sequencing the genomes of the 100 Over 100 presents an unprecedented opportunity to identify those "rare genes" that protect against diseases, while giving researchers valuable clues to health and longevity. These centenarians’ genes are providing us with a window to the past that will significantly impact the future of healthcare.

The result will be the world's first "medical grade” genome, a critically needed clinical standard that will transform genomic research into usable medical information to improve patient diagnosis and treatment. This global competition will inspire breakthrough genome sequencing innovations and technologies that will usher in a new era of personalized medicine.


Read more about this topic:  Archon X Prize